Long-Term Results from an Open-Label Extension Study of Atacicept for the Treatment of IgA Nephropathy.

ABSTRACT:

SUBMITTER: Barratt J 

PROVIDER: S-EPMC7616790 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature